# Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)

> **NCT04483167** · PHASE1 · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 13 (actual)

## Conditions studied

- Cardiovascular Diseases
- Atherosclerosis

## Interventions

- **DRUG:** 99mTccAbVCAM1-5 injection

## Key facts

- **NCT ID:** NCT04483167
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-15
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04483167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04483167, "Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04483167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*